NCT04126551View on ClinicalTrials.gov

Mitochondrial Methylation in Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

July 23, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
OverweightObesityDiabetes Mellitus, Type 2Insulin Resistance
Interventions
OTHER

Methylation status

Participants will be recruited, and muscle biopsies will be obtained for methylation analyses and measuring mitochondrial function

Trial Locations (1)

85724

Clinical and Translational Research Center (CaTS), Tucson

All Listed Sponsors
lead

University of Arizona

OTHER

NCT04126551 - Mitochondrial Methylation in Type 2 Diabetes | Biotech Hunter | Biotech Hunter